Cervical cancer, 8 HPV types in focus
eHEALTH Bureau
Scientists have identified the eight human papillomavirus (HPV) types responsible for more than 90% of cervical cancer cases worldwide and say they should be the targets for the next generation of vaccines.
Drug makers GlaxoSmithKline (GSK) and Merck and Co already make vaccines against HPV strains that cause many cases of cervical cancer, which is the second most common cancer in women worldwide and is expected to kill 328,000 this year.
In a large study looking at 60 years of data from 10,575 cases of invasive cervical cancer across 38 countries, an international team of scientists led by Silvia de Sanjose of the Catalan Institute of Oncology in Barcelona examined which types of HPV contributed most to the global incidence of the disease. Their results, published in The Lancet medical journal on Monday, showed eight HPV types
post_id:
uld_count:
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
